Anticipatory CINV
- 2021 CPG Update – Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2014 CPG – Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of our processes, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
Bruce Power and supplier partners donate $100,000 to Pediatric Oncology Group of Ontario
Originally published on the Bruce Power website, September 25, 2024
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways
YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.